IDWeek 2018

A dedicated infectious disease stewardship program can have immediate impact on patient safety, treatment of appropriate disease states, and the reduction of unnecessary readmission to the acute care hospital.
The US Food and Drug Administration has approved omadacycline for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
In 2 parallel phase 3 trials, the diaminopyrimidine reductase inhibitor iclaprim showed noninferiority compared with vancomycin for the treatment of wound infections.
Omadacycline is a new intravenous/oral antibiotic for patients presenting in the emergency department with acute bacterial skin and soft tissue infections.
The use of oritavancin is a strategy to address the high economic burden secondary to prolonged hospitalization and high rates of recurrent infections associated with acute bacterial skin and skin structure infections.
Eravacycline 1 mg/kg every 12 hours was demonstrated to be noninferior to ertapenem 1 g intravenously every 24 hours or meropenem in patients with complicated intra-abdominal infections.
Can costs associated with community-acquired bacterial pneumonia be reduced by implementing the site-of-care indicators regarding severity of illness recommended in the IDSA/ATS CAP guidelines?
Socioeconomic factors play a significant role in hospital readmission following outpatient parenteral antimicrobial therapy.
Omadacycline provides significant improvement in the physical component of quality of life for adult subjects with an acute bacterial skin and skin structure infection known or suspected to be due to a Gram-positive pathogen.
Researchers compared epidemiologic and healthcare resource utilization data on Escherichia coli community-acquired bacterial pneumonia with that of pneumococcal community-acquired bacterial pneumonia.
Page 2 of 3
Results 11 - 20 of 23
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME